Echinocystic acid prevents obesity and fatty liver via interacting with FABP1
Phytotherapy Research · 2023-08 · 37 (8) · 3617-3630
DOI: 10.1002/ptr.7839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 24.04.2023. Verfasst von Lianggui Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Hauptthemen laut MEDLINE: Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Guangxi Digestive Disease Clinical Medical Research Center Construction Project, Guangxi Health Commission Key Laboratory of Portal Hypertension Prevention and Control Research, Guangxi Science Foundation for Distinguished Young Scholars.
Abstract (Originalsprache)
Long‐term high‐fat diet (HFD) will lead to obesity and their complications. Echinocystic acid (EA), a triterpene, shows anti‐inflammatory and antioxidant effects. We predict that EA supplementation can prevent obesity, diabetes, and nonalcoholic steatohepatitis. To test our hypothesis, we investigated the effects of EA supplementation on mice with HFD‐induced obesity in vivo and in vitro by adding EA to the diet of mice and the medium of HepG2 cells, the protein target of EA was analyzed by molecular docking. The results showed that EA ameliorated obesity and inhibited blood triglyceride and liver triglyceride concentrations than those in the HFD groups. The data on molecular docking indicated that FABP1 was a potential target of EA. Further experimental results confirmed that EA affected the triglyceride level by regulating the function of FABP1. This study may provide a new potential inhibitor for FABP1 and a new strategy for the treatment of obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- College of Animal Science and Technology, Guangxi University, Nanning, China.
Förderung
- Guangxi Digestive Disease Clinical Medical Research Center Construction Project
- Guangxi Health Commission Key Laboratory of Portal Hypertension Prevention and Control Research
- Guangxi Science Foundation for Distinguished Young Scholars
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
Zitieren
APA
Xiao, L., Li, M., Xiao, Y., Yu, L., Li, Y., Zhang, Z., Zhang, G., Li, Y., Zhou, L., & Liang, Y. (2023). Echinocystic acid prevents obesity and fatty liver via interacting with FABP1. Phytotherapy Research, 37(8), 3617-3630. https://doi.org/10.1002/ptr.7839
Vancouver
Xiao L, Li M, Xiao Y, Yu L, Li Y, Zhang Z, et al. Echinocystic acid prevents obesity and fatty liver via interacting with FABP1. Phytotherapy Research. 2023;37(8):3617-3630. doi:10.1002/ptr.7839
BibTeX
@article{Xiao2023,
author = {Xiao, Lianggui and Li, Mingming and Xiao, Yang and Yu, Lin and Li, Yu and Zhang, Zhiwang and Zhang, Guo and Li, Yixing and Zhou, Lei and Liang, Yunxiao},
title = {Echinocystic acid prevents obesity and fatty liver via interacting with FABP1},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {8},
pages = {3617--3630},
doi = {10.1002/ptr.7839}
}
EUVIMED